TradingAgents AISign inGet started
All stock profiles
DBVTNASDAQHealthcare

DBV TECHNOLOGIES SA

Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.

Latest price

$9.49

-7.77%

Alpha Vantage · 10/30/2026

Industry: BiotechnologyCategory: ADR Common StockCurrency: USDNews: 0 recent
Analyze DBVT free

One-year price history

Adjusted daily closes · 252 observations · as of Oct 30, 2026

Historical data, not a forecast

1 month

-15.3%

3 months

-30.1%

6 months

-52.2%

1 year

-32.6%

Year to date

-50.5%

52-week range

$8.87 – $24.54

Fundamental snapshot

Latest reported period: Sep 30, 2026

Sharadar reported data

Market cap

$596.7M

P/E

-2.9

P/B

4

P/S

155.2

Revenue

$3.85M

Net income

-$207.33M

Diluted EPS

-3

Gross margin

100.00%

Net margin

-5392.20%

Return on equity

-120.90%

Total debt

$7.5M

Cash

$165.7M

Free cash flow

-$191.75M

Latest eight reported quarters

Reported quarterly values, newest first

PeriodRevenueNet incomeGross marginNet marginFree cash flow
Sep 30, 2026$1.6M-$64.5M100.00%-4031.20%-$53.7M
Jun 30, 2026$700K-$50.4M100.00%-7200.00%-$53M
Mar 31, 2026$900K-$47.6M100.00%-5288.90%-$49.5M
Dec 31, 2025$645K-$44.83M100.00%-6950.20%-$35.55M
Sep 30, 2025$2.77M-$33.16M100.00%-1195.50%-$32.55M
Jun 30, 2025$1.47M-$41.88M100.00%-2858.40%-$33.94M
Mar 31, 2025$753K-$27.08M100.00%-3596.10%-$19.68M
Dec 31, 2024$511K-$23.02M100.00%-4503.90%-$12.13M

Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.

Recent DBVT news

All market news

No ticker-linked stories are in the current archive.